SBIR-STTR Award

Instrument objectively to measure visual glare disability
Award last edited on: 6/2/2009

Sponsored Program
SBIR
Awarding Agency
NIH : NEI
Total Award Amount
$461,581
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Peter Magnante

Company Information

Brookfield Optical Systems (AKA: Peter Magnante)

218 Wigwam Road
West Brookfield, MA 01585
   (508) 867-6675
   N/A
   N/A
Location: Single
Congr. District: 02
County: Worcester

Phase I

Contract Number: 1R43EY009666-01A1
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1993
Phase I Amount
$44,997
A non-invasive ophthalmic instrument that measures the inability of cataractous eyes to produce clear images is greatly needed. A prototype instrument was developed in Phase I to measure the width of the Line Spread Function (LSF) formed on the retina. In clinical studies, the LSF-width was found to be correlated with several indicators of cataract development, namely 1) increased glare sensitivity, 2) loss of contrast sensitivity, 3) loss of visual acuity, and 4) increased lens opacification observed with the slit lamp. In Phase II, we will refine the instrument by developing a more sensitive detection method that will allow the Modulation Transfer Function (MTF) to be accurately determined. Clinical studies will be conducted 1) to investigate if a patient's contrast sensitivity (CS) function (determined by chart testing) can be predicted from the optical MTF and the neural contrast sensitivity function (determined using laser interference fringes), 2) to investigate the influence on the extent of nuclear cataract on the MTF, 3) to compare the relative significance of CS tests and MTF tests for detecting change in the eyes of Visual function following cataract surgery and 4) to determine the sensitivities of CS tests, MTF tests and visual acuity tests to the extent of cataract development as assessed during slit lamp examination.National Eye Institute (NEI)

Phase II

Contract Number: 2R44EY009666-02
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
1995
(last award dollars: 1996)
Phase II Amount
$416,584

Description: A non-invasive ophthalmic instrument that measures the inability of cataractous eyes to produce clear images is greatly needed. A prototype instrument was developed in Phase I to measure the width of the Line Spread Function (LSF) formed on the retina. In clinical studies, the LSF-width was found to be correlated with several indicators of cataract development, namely 1) increased glare sensitivity, 2) loss of contrast sensitivity, 3) loss of visual acuity, and 4) increased lens opacification observed with the slit lamp. In Phase II, we will refine the instrument by developing a more sensitive detection method that will allow the Modulation Transfer Function (MTF) to be accurately determined. Clinical studies will be conducted, 1) to investigate if a patient's contrast sensitivity (CS) function (determined by chart testing) can be predicted from the optical MTF and the neural contrast sensitivity function (determined using laser interference fringes), 2) to investigate the influence on the extent of nuclear cataract on the MTF, 3) to compare the relative significance of CS tests and MTF tests for detecting change in the eyes of Visual function following cataract surgery and 4) to determine the sensitivities of CS tests, MTF tests and visual acuity tests to the extent of cataract development as assessed during slit lamp examination